European Circular Bioeconomy Fund
The European Circular Bioeconomy Fund, established in 2020 and managed by ECBF Management, is a later-stage venture capital fund based in Bonn, Germany. It focuses on investing in entrepreneurs and companies that are advancing the circular bioeconomy, particularly within the biotechnology and life sciences sectors. The fund prioritizes impact investments, aligning with sustainable practices and contributing to environmental goals. As an Article 9 fund under the EU Sustainable Finance Disclosure Regulation (SFDR), it emphasizes responsible investment strategies that promote ecological benefits while supporting the growth of innovative businesses in the circular economy.
Top Sectors
Past deals in Pest Control
Aphea.Bio
Series C in 2023
Aphea.Bio is a company focused on developing next-generation biopesticides and biostimulants derived from natural microorganisms. Its biopesticides serve as an alternative to conventional chemical pesticides, addressing the increasing pressure on synthetic chemical use in agriculture. Additionally, the company creates biostimulants that enhance crop growth by improving the uptake of nutrients from the soil. Aphea.Bio's products aim to sustainably increase crop yields and health, specifically targeting crops such as maize and wheat. By utilizing proprietary technologies, the company accelerates the discovery of innovative biocontrol and biostimulant solutions, enabling farmers to manage pests, diseases, and fertilizer application more effectively.
Trapview
Series B in 2022
Trapview's vision is to create innovative solutions and services that help growers grow healthier food while protecting the environment. Trapview leverages AI to monitor pests and predict outbreaks, empowering farmers to reduce insecticide use, lower food chemical residues, cut production costs, and decrease CO2 emissions from crop protection, fostering sustainable farming practices.
Aphea.Bio
Series B in 2021
Aphea.Bio is a company focused on developing next-generation biopesticides and biostimulants derived from natural microorganisms. Its biopesticides serve as an alternative to conventional chemical pesticides, addressing the increasing pressure on synthetic chemical use in agriculture. Additionally, the company creates biostimulants that enhance crop growth by improving the uptake of nutrients from the soil. Aphea.Bio's products aim to sustainably increase crop yields and health, specifically targeting crops such as maize and wheat. By utilizing proprietary technologies, the company accelerates the discovery of innovative biocontrol and biostimulant solutions, enabling farmers to manage pests, diseases, and fertilizer application more effectively.
Aphea.Bio
Series B in 2020
Aphea.Bio is a company focused on developing next-generation biopesticides and biostimulants derived from natural microorganisms. Its biopesticides serve as an alternative to conventional chemical pesticides, addressing the increasing pressure on synthetic chemical use in agriculture. Additionally, the company creates biostimulants that enhance crop growth by improving the uptake of nutrients from the soil. Aphea.Bio's products aim to sustainably increase crop yields and health, specifically targeting crops such as maize and wheat. By utilizing proprietary technologies, the company accelerates the discovery of innovative biocontrol and biostimulant solutions, enabling farmers to manage pests, diseases, and fertilizer application more effectively.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.